On August 29, 2025, vTv Therapeutics Inc. announced a private placement of 5,243,732 units, generating approximately $80 million in gross proceeds. Each unit consists of a share of Class A common stock or a pre-funded warrant, with corresponding warrants for future shares, subject to certain ownership limitations.